56 related articles for article (PubMed ID: 20601654)
1. A systematic review of the safety of non-tumour necrosis factor inhibitor and targeted synthetic drugs in rheumatic disease in pregnancy.
Ahmed K; Giles I; Nguyen H; Flint J
Clin Med (Lond); 2020 Mar; 20(Suppl 2):s98. PubMed ID: 32409405
[No Abstract] [Full Text] [Related]
2. Long-Term Benefit of Perlingual Polybacterial Vaccines in Patients with Systemic Autoimmune Diseases and Active Immunosuppression.
Pérez-Sancristóbal I; de la Fuente E; Álvarez-Hernández MP; Guevara-Hoyer K; Morado C; Martínez-Prada C; Freites-Nuñez D; Villaverde V; Fernández-Arquero M; Fernández-Gutiérrez B; Sánchez-Ramón S; Candelas G
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189785
[TBL] [Abstract][Full Text] [Related]
3. Lebanese Hospital-Based Rheumatoid Arthritis Registry: Characteristics of Patients and Comparison with Other Populations.
Ziadeh H; Chaaya M; Rachidi S; Asmar KE; Al-Hajje A; Hamieh L; Nahra V; Uthman I
Mediterr J Rheumatol; 2022 Jun; 33(2):218-223. PubMed ID: 36128213
[TBL] [Abstract][Full Text] [Related]
4. Conception of National Biologics Registry for Pediatric Rheumatology: Need of the Hour and the Way Forward.
Bagri NK; Kumar S; Ramanan AV
Indian Pediatr; 2022 Dec; 59(12):913-915. PubMed ID: 36089846
[TBL] [Abstract][Full Text] [Related]
5. Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years.
Sánchez-Piedra C; Sueiro-Delgado D; García-González J; Ros-Vilamajo I; Prior-Español A; Moreno-Ramos MJ; Garcia-Magallon B; Calvo-Gutiérrez J; Perez-Vera Y; Martín-Domenech R; Ruiz-Montesino D; Vela-Casasempere P; Expósito L; Sánchez-Alonso F; González-Davila E; Díaz-González F
Sci Rep; 2021 Jul; 11(1):15051. PubMed ID: 34302036
[TBL] [Abstract][Full Text] [Related]
6. Sublingual Bacterial Vaccination Reduces Recurrent Infections in Patients With Autoimmune Diseases Under Immunosuppressant Treatment.
Sánchez-Ramón S; Fernández-Paredes L; Saz-Leal P; Diez-Rivero CM; Ochoa-Grullón J; Morado C; Macarrón P; Martínez C; Villaverde V; de la Peña AR; Conejero L; Hernández-Llano K; Cordero G; Fernández-Arquero M; Gutierrez BF; Candelas G
Front Immunol; 2021; 12():675735. PubMed ID: 34149711
[TBL] [Abstract][Full Text] [Related]
7. Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry.
Prior-Español A; Sánchez-Piedra C; Campos J; Manero FJ; Pérez-García C; Bohórquez C; Busquets-Pérez N; Blanco-Madrigal JM; Díaz-Torne C; Sánchez-Alonso F; Mateo L; Holgado-Pérez S
Sci Rep; 2021 May; 11(1):11091. PubMed ID: 34045525
[TBL] [Abstract][Full Text] [Related]
8. Adding value to real-world data: the role of biomarkers.
Plant D; Barton A
Rheumatology (Oxford); 2020 Jan; 59(1):31-38. PubMed ID: 31329972
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.
Mercer LK; Regierer AC; Mariette X; Dixon WG; Baecklund E; Hellgren K; Dreyer L; Hetland ML; Cordtz R; Hyrich K; Strangfeld A; Zink A; Canhao H; Hernandez MV; Tubach F; Gottenberg JE; Morel J; Zavada J; Iannone F; Askling J; Listing J
Ann Rheum Dis; 2017 Dec; 76(12):2025-2030. PubMed ID: 28822981
[TBL] [Abstract][Full Text] [Related]
10. Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review.
Luo Y; Thompson WK; Herr TM; Zeng Z; Berendsen MA; Jonnalagadda SR; Carson MB; Starren J
Drug Saf; 2017 Nov; 40(11):1075-1089. PubMed ID: 28643174
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of off-label drug uses in hospitals: a multicentric prospective study.
Danés I; Agustí A; Vallano A; Alerany C; Martínez J; Bosch JA; Ferrer A; Gratacós L; Pérez A; Olmo M; Marron SM; Valderrama A; Bonafont X
Eur J Clin Pharmacol; 2014 Nov; 70(11):1385-93. PubMed ID: 25196202
[TBL] [Abstract][Full Text] [Related]
12. Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: data from the Spanish registry BIOBADASER 2.0.
Cobo-Ibáñez T; Descalzo MÁ; Loza-Santamaría E; Carmona L; Muñoz-Fernández S
Rheumatol Int; 2014 Jul; 34(7):953-61. PubMed ID: 24414744
[TBL] [Abstract][Full Text] [Related]
13. Therapy: Off-label biologics use and infection risk-the great unknown.
Winthrop KL; Smolen JS
Nat Rev Rheumatol; 2011 Oct; 7(12):685-6. PubMed ID: 21989283
[No Abstract] [Full Text] [Related]
14. Review of clinical registries of psoriatic arthritis: lessons learned?: value for the future?
Gladman DD; Chandran V
Curr Rheumatol Rep; 2011 Aug; 13(4):346-52. PubMed ID: 21494786
[TBL] [Abstract][Full Text] [Related]
15. Safety and retention rate of off-label uses of TNF antagonists in rheumatic conditions: data from the Spanish registry BIOBADASER 2.0.
Carmona L; Descalzo MA; Ruiz-Montesinos D; Manero-Ruiz FJ; Perez-Pampin E; Gomez-Reino JJ;
Rheumatology (Oxford); 2011 Jan; 50(1):85-92. PubMed ID: 20601654
[TBL] [Abstract][Full Text] [Related]
16. Cancer in patients with rheumatic diseases exposed to TNF antagonists.
Carmona L; Abasolo L; Descalzo MA; Pérez-Zafrilla B; Sellas A; de Abajo F; Gomez-Reino JJ; ;
Semin Arthritis Rheum; 2011 Aug; 41(1):71-80. PubMed ID: 21093020
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: study using the Spanish registry of adverse events of biological therapies in rheumatic diseases.
Hernández MV; Sanmartí R; Cañete JD; Descalzo MA; Alsina M; Carmona L; Gomez-Reino JJ;
Arthritis Care Res (Hoboken); 2013 Dec; 65(12):2024-31. PubMed ID: 23926075
[TBL] [Abstract][Full Text] [Related]
18. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.
Gómez-Reino JJ; Carmona L; Angel Descalzo M;
Arthritis Rheum; 2007 Jun; 57(5):756-61. PubMed ID: 17530674
[TBL] [Abstract][Full Text] [Related]
19. Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review.
Cruz Fernández-Espartero M; Pérez-Zafrilla B; Naranjo A; Esteban C; Ortiz AM; Gómez-Reino JJ; Carmona L;
Semin Arthritis Rheum; 2011 Dec; 41(3):524-33. PubMed ID: 22152489
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
